Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9006 |
High Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.8848 |
High Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.8596 |
High Similarity |
NPD6595 |
Phase 3 |
0.8421 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD8073 |
Approved |
0.837 |
Intermediate Similarity |
NPD8072 |
Approved |
0.8363 |
Intermediate Similarity |
NPD482 |
Approved |
0.8305 |
Intermediate Similarity |
NPD8431 |
Approved |
0.8295 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.8286 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.8286 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.8226 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.8221 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.8218 |
Intermediate Similarity |
NPD4079 |
Approved |
0.8218 |
Intermediate Similarity |
NPD4076 |
Approved |
0.8182 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD786 |
Approved |
0.8161 |
Intermediate Similarity |
NPD3505 |
Approved |
0.8161 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD3506 |
Approved |
0.8161 |
Intermediate Similarity |
NPD2144 |
Approved |
0.815 |
Intermediate Similarity |
NPD5065 |
Approved |
0.811 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.8075 |
Intermediate Similarity |
NPD1722 |
Approved |
0.8047 |
Intermediate Similarity |
NPD1404 |
Approved |
0.8047 |
Intermediate Similarity |
NPD1403 |
Approved |
0.8035 |
Intermediate Similarity |
NPD3610 |
Approved |
0.8035 |
Intermediate Similarity |
NPD3609 |
Approved |
0.8023 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.8023 |
Intermediate Similarity |
NPD2640 |
Approved |
0.8023 |
Intermediate Similarity |
NPD2641 |
Approved |
0.8023 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7978 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD2642 |
Approved |
0.7965 |
Intermediate Similarity |
NPD2639 |
Approved |
0.7919 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD5590 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD5106 |
Approved |
0.7877 |
Intermediate Similarity |
NPD5105 |
Approved |
0.7874 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7874 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7849 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7844 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.7844 |
Intermediate Similarity |
NPD4463 |
Approved |
0.7844 |
Intermediate Similarity |
NPD4462 |
Approved |
0.7841 |
Intermediate Similarity |
NPD4128 |
Approved |
0.7772 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.7766 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7732 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD1661 |
Suspended |
0.7714 |
Intermediate Similarity |
NPD4640 |
Approved |
0.7714 |
Intermediate Similarity |
NPD4639 |
Approved |
0.7714 |
Intermediate Similarity |
NPD4638 |
Approved |
0.7709 |
Intermediate Similarity |
NPD8386 |
Phase 2 |
0.7705 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD1038 |
Approved |
0.7688 |
Intermediate Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.7656 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD4703 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7617 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.7617 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD5818 |
Discontinued |
0.7577 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD4181 |
Approved |
0.7543 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.7538 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2719 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2720 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD5315 |
Discontinued |
0.7474 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.747 |
Intermediate Similarity |
NPD3943 |
Clinical (unspecified phase) |
0.7463 |
Intermediate Similarity |
NPD7711 |
Discontinued |
0.7462 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD484 |
Approved |
0.7447 |
Intermediate Similarity |
NPD3404 |
Approved |
0.7425 |
Intermediate Similarity |
NPD1592 |
Phase 3 |
0.7424 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7424 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD7970 |
Approved |
0.74 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.7387 |
Intermediate Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.7387 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD8026 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD2385 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD3015 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7366 |
Intermediate Similarity |
NPD6217 |
Discontinued |
0.735 |
Intermediate Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD5138 |
Approved |
0.7345 |
Intermediate Similarity |
NPD5140 |
Approved |
0.7337 |
Intermediate Similarity |
NPD5254 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD5021 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD4779 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5100 |
Phase 3 |
0.7288 |
Intermediate Similarity |
NPD972 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD1853 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD6277 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD4637 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD706 |
Phase 1 |
0.7258 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD1528 |
Clinical (unspecified phase) |
0.7249 |
Intermediate Similarity |
NPD5117 |
Phase 2 |
0.7249 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7241 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD2012 |
Clinical (unspecified phase) |
0.724 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD3476 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3475 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD4865 |
Approved |
0.7216 |
Intermediate Similarity |
NPD1315 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD6044 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD4547 |
Phase 3 |
0.7206 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD3843 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD3654 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD2006 |
Phase 2 |
0.7175 |
Intermediate Similarity |
NPD5255 |
Approved |
0.7168 |
Intermediate Similarity |
NPD2430 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD2119 |
Approved |
0.716 |
Intermediate Similarity |
NPD2118 |
Approved |
0.716 |
Intermediate Similarity |
NPD991 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD992 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD2928 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD6148 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3117 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2310 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3116 |
Approved |
0.7135 |
Intermediate Similarity |
NPD3401 |
Clinical (unspecified phase) |
0.7129 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7127 |
Intermediate Similarity |
NPD5862 |
Discovery |
0.712 |
Intermediate Similarity |
NPD4949 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7108 |
Intermediate Similarity |
NPD3385 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD4112 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD9583 |
Approved |
0.7092 |
Intermediate Similarity |
NPD5043 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6476 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD6158 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD4615 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD5067 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD704 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD5066 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD3469 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD2007 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.7071 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD6492 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD2580 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD276 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD4511 |
Phase 1 |
0.7056 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD1683 |
Approved |
0.705 |
Intermediate Similarity |
NPD1392 |
Approved |
0.7047 |
Intermediate Similarity |
NPD2717 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD3330 |
Phase 1 |
0.7043 |
Intermediate Similarity |
NPD8036 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD8037 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD5828 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD3825 |
Phase 3 |
0.7041 |
Intermediate Similarity |
NPD2896 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD3813 |
Approved |
0.7035 |
Intermediate Similarity |
NPD751 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD4509 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD6173 |
Approved |
0.7031 |
Intermediate Similarity |
NPD1235 |
Phase 3 |
0.7031 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD2381 |
Approved |
0.7027 |
Intermediate Similarity |
NPD3348 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD2382 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2380 |
Approved |
0.7024
|
Intermediate Similarity |
NPD792 |
Discontinued |